Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 7, 2011, Pages 1807-1811

  Liang, Rong ^a   Bai, Qing Xian ^a   Zhang, Yong Qing ^a   Zhang, Tao ^a   Yang, Lan ^a   Wang, Yi Wei ^a   Zhu, Hua Feng ^a   Wang, Wen Qing ^a   Gu, Hong Tao ^a   Gao, Guang Xun ^a   Shu, Mi Mi ^a   Chen, Xie Quan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Etoposide cytrarabine; Hyperleukocytic acute leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; ETOPOSIDE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LEUKOSTASIS; MALE; MIDDLE AGED; MORTALITY; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CYTARABINE; ETOPOSIDE; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOSTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; YOUNG ADULT;

EID: 84864334774     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Apostolidou E, Swords R, Alvarado Y, Giles FJ (2007). Treatment of acute lymphoblastic leukaemia: a new era. Drugs, 67, 2153-71.
2. Chang MC, Chen TY, Tang JL, et al (2007). Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol, 82, 976-80.
3. Creutzig U, Buchner T, Sauerland MC, et al (2008). Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Cancer, 112, 562-71.
4. Greenwood MJ, Seftel MD, Richardson C, et al (2006). Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma, 47, 1245-52.
5. Griffin TC, Weitzman S, Weinstein H, et al (2009). A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer, 52, 177-81.
6. Haase R, Merkel N, Diwan O, Elsner K, Kramm CM (2009). Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Pediatr, 221, 374-8.
7. Inaba H, Fan Y, Pounds S, et al (2008). Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer, 113, 522-9.
8. Marbello L, Ricci F, Nosari AM, et al (2008). Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res, 32, 1221-7.
9. Nau KC, Lewis WD (2008). Multiple myeloma: diagnosis and treatment. Am Fam Physician, 78, 853-9.
10. Oliveira LC, Romano LG, Prado-Junior BP, et al (2010). Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol, 27, 1254-9.
11. Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M (2009). Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol, 121, 56-62.
12. Ruggiero A, Attinà G, Piastra M, et al (2009). Severe hyperleukocytosis and multifocal intracranial haemorrhage: not always a fatal outcome. Int J Hematol, 90, 87-90.
13. Wald BR, Heisel MA, Ortega JA (1982). Frequency of early death in children with acute leukemia presenting with hyperleukocytosis. Cancer, 50, 150-3.
14. Wang X, Lin G, Wang J (1997). 244 patients with hyperleukocytic acute leukemia. Shanghai Leukemia Cooperation Group. Chin J Int Med, 36, 532-5 (in Chinese).